Pharming Group (NASDAQ:PHAR) and Earth Science Tech (OTCMKTS:ETST) Financial Analysis

Earth Science Tech (OTCMKTS:ETST) and Pharming Group (NASDAQ:PHAR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Profitability

This table compares Earth Science Tech and Pharming Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Earth Science Tech	10.02%	73.51%	44.22%
Pharming Group	0.71%	1.08%	0.59%

Analyst Ratings

This is a breakdown of current recommendations and price targets for Earth Science Tech and Pharming Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Earth Science Tech	0	0	0	0	0.00
Pharming Group	0	2	3	0	2.60

Pharming Group has a consensus target price of $38.33, suggesting a potential upside of 116.82%. Given Pharming Group’s stronger consensus rating and higher probable upside, analysts clearly believe Pharming Group is more favorable than Earth Science Tech.

Insider and Institutional Ownership

0.0% of Pharming Group shares are owned by institutional investors. 24.9% of Earth Science Tech shares are owned by insiders. Comparatively, 2.1% of Pharming Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Earth Science Tech and Pharming Group”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Earth Science Tech	$33.12 million	1.05	$3.25 million	N/A	N/A
Pharming Group	$376.13 million	3.30	$2.85 million	$0.01	1,768.00

Earth Science Tech has higher earnings, but lower revenue than Pharming Group.

Volatility and Risk

Earth Science Tech has a beta of 2.09, suggesting that its share price is 109% more volatile than the S&P 500. Comparatively, Pharming Group has a beta of 0.05, suggesting that its share price is 95% less volatile than the S&P 500.

About Earth Science Tech

Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.